{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_14320", "batch_size": 200, "batch_pos": 172, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment contains no high-potency verbs, potent metaphors, or other Q2 cues.", "method": "llm_batch", "batch_id": "batch_2_9228", "batch_size": 200, "batch_pos": 137, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "No moderate verb from the approved list is present.", "method": "llm_batch", "batch_id": "batch_3_11468", "batch_size": 200, "batch_pos": 75, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment is a statement, not a question.", "method": "llm_batch", "batch_id": "batch_4_6080", "batch_size": 200, "batch_pos": 61, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports trial focus, not explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_21500", "batch_size": 200, "batch_pos": 54, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_18308", "batch_size": 200, "batch_pos": 6, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_20452", "batch_size": 200, "batch_pos": 194, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment states 'The late-stage trial would likely focus on safety and immune response', describing the focus of a future trial (development/testing).", "method": "llm_batch", "batch_id": "batch_8_16560", "batch_size": 200, "batch_pos": 169, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
